Can-Fite BioPharma CANF
NYSE CANF
$1.92 +0.03 (+1.60%)
As of: Oct 20, 2026 · 1:06 PM EDT

Can-Fite BioPharma (CANF) EPS (Diluted) (2020 - 2023)

Updated

Can-Fite BioPharma (CANF) recorded EPS (Diluted) of -$11.94 in FY2025, compared with -$0.14 in FY2024.

Analysis

Can-Fite BioPharma (CANF) EPS (Diluted) (2020 - 2023) Analysis & Trends

Starting with FY2020, Can-Fite BioPharma's EPS (Diluted) history includes 6 years.

  • The FY2025 figure is the lowest annual EPS (Diluted) in data going back to FY2020.
  • Per Business Quant data, CANF's EPS (Diluted) was -$0.14 in FY2024, -$0.24 in FY2023, -$0.37 in FY2022 and -$0.73 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.94
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.27
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.04
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -0.54
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.67
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.60
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.37
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -8.44
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -0.04
10 Can-Fite BioPharma 1.58 Mn -18.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -0.05
Sep 30, 2023 -0.09
Jun 30, 2023 0.12
Mar 31, 2023 -0.13
Dec 31, 2022 -0.02
Sep 30, 2022 -0.18
Jun 30, 2022 0.18
Mar 31, 2022 -0.18
Dec 31, 2021 -0.30
Sep 30, 2021 -0.38
Jun 30, 2021 -0.36
Mar 31, 2021 -0.21
Dec 31, 2020 -0.41
API Access

Can-Fite BioPharma EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=CANF&period=max&api_key=YOUR_API_KEY